Major Pathologic Response Improves Outcomes in Pancreatic Cancer
Achieving a major pathologic response (mpr) after preoperative treatment for pancreatic ductal adenocarcinoma significantly impacts survival rates.
Newsletter
Best Papers in General Surgery
The five that matter, every day.
Achieving a major pathologic response (mpr) after preoperative treatment for pancreatic ductal adenocarcinoma significantly impacts survival rates.
Patients with isolated pulmonary metastases post-resection of pancreatic ductal adenocarcinoma (PDAC) have improved overall survival compared to other metastatic sites.
Endoscopic submucosal dissection (ESD) offers compelling insights into managing T1 colorectal cancer (CRC), shaping surgical strategies.
Rationalizing surgical trays for elective procedures can save money and reduce environmental impact.
Targeted endoscopic approaches offer symptom relief in chronic pancreatitis but surgery is preferred for long-term outcomes.
Patients with stage I-III colon cancer face higher locoregional recurrence and lower survival rates when complications occur.
Total neoadjuvant therapy does not change the selection criteria for lateral pelvic lymph node dissection in rectal cancer.
Postoperative pancreatic fistula (POPF) significantly hampers chemotherapy delivery in pancreatic cancer patients.
Performing cholecystectomy at the same admission for patients with choledocholithiasis-associated cholangitis significantly lowers complications and readmissions.
Endoscopic ultrasound-guided gallbladder drainage is now more effective than traditional methods for patients unfit for surgery.